387 related articles for article (PubMed ID: 21501644)
1. Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilance.
Kurz X; Domergue F; Slattery J; Segec A; Szmigiel A; Hidalgo-Simon A
Vaccine; 2011 Jun; 29(26):4378-87. PubMed ID: 21501644
[TBL] [Abstract][Full Text] [Related]
2. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous reporting of adverse events following immunisation against pandemic influenza in Denmark November 2009-March 2010.
Folkenberg M; Callréus T; Svanström H; Valentiner-Branth P; Hviid A
Vaccine; 2011 Feb; 29(6):1180-4. PubMed ID: 21172382
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10.
Emborg HD; Krause TG; Hviid A; Simonsen J; Mølbak K
BMJ; 2011 Jan; 344():d7901. PubMed ID: 22277542
[TBL] [Abstract][Full Text] [Related]
5. Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program.
Salmon DA; Akhtar A; Mergler MJ; Vannice KS; Izurieta H; Ball R; Lee GM; Vellozzi C; Garman P; Cunningham F; Gellin B; Koh H; Lurie N;
Pediatrics; 2011 May; 127 Suppl 1():S78-86. PubMed ID: 21502251
[TBL] [Abstract][Full Text] [Related]
6. Monitoring adverse events of vaccines against Mexican flu.
van Puijenbroek EP; van Grootheest AC
Int J Risk Saf Med; 2011; 23(2):81-7. PubMed ID: 21673415
[TBL] [Abstract][Full Text] [Related]
7. Italian post-marketing surveillance for adverse event reports after MF59-adjuvanted H1N1v vaccination.
Parretta E; Ianniello B; Ferrazin F; Rossi F; Capuano A
Vaccine; 2011 May; 29(20):3708-13. PubMed ID: 21406267
[TBL] [Abstract][Full Text] [Related]
8. The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: a capture-recapture analysis.
Huang WT; Huang WI; Huang YW; Hsu CW; Chuang JH
Vaccine; 2012 Mar; 30(12):2168-72. PubMed ID: 22265861
[TBL] [Abstract][Full Text] [Related]
9. Vaccines against influenza A (H1N1) pandemic.
Valdespino-Gomez JL; Garcia-Garcia L; de León-Rosales SP
Arch Med Res; 2009 Nov; 40(8):693-704. PubMed ID: 20304259
[TBL] [Abstract][Full Text] [Related]
10. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010.
Vellozzi C; Broder KR; Haber P; Guh A; Nguyen M; Cano M; Lewis P; McNeil MM; Bryant M; Singleton J; Martin D; DeStefano F
Vaccine; 2010 Oct; 28(45):7248-55. PubMed ID: 20850534
[TBL] [Abstract][Full Text] [Related]
11. [Variability in the reporting of adverse reactions to the pandemic and seasonal influenza vaccine: seasons 2009-2010 and 2010-2011. Valencian community, Spain].
Alguacil Ramos AM; Lluch Rodrigo JA; Portero Alonso A; Martín Ivorra R; Pastor Villalba E
Rev Esp Salud Publica; 2012; 86(3):241-51. PubMed ID: 22991081
[TBL] [Abstract][Full Text] [Related]
12. Safety of pandemic H1N1 vaccines in children and adolescents.
Wijnans L; de Bie S; Dieleman J; Bonhoeffer J; Sturkenboom M
Vaccine; 2011 Oct; 29(43):7559-71. PubMed ID: 21821086
[TBL] [Abstract][Full Text] [Related]
13. Active surveillance of adverse events following immunization against pandemic influenza A (H1N1) in Korea.
Choe YJ; Cho H; Song KM; Kim JH; Han OP; Kwon YH; Bae GR; Lee HJ; Lee JK
Jpn J Infect Dis; 2011; 64(4):297-303. PubMed ID: 21788704
[TBL] [Abstract][Full Text] [Related]
14. [Attitudes and side effects related to pandemic influenza A (H1N1) vaccination in healthcare personnel].
Ormen B; Türker N; Vardar I; Kaptan F; El S; Ural S; Kaya F; Coşkun NA
Mikrobiyol Bul; 2012 Jan; 46(1):57-64. PubMed ID: 22399172
[TBL] [Abstract][Full Text] [Related]
15. Pandemic 2009 H1N1 influenza virus vaccination in lung transplant recipients: coverage, safety and clinical effectiveness in the Zurich cohort.
Schuurmans MM; Tini GM; Dalar L; Fretz G; Benden C; Boehler A
J Heart Lung Transplant; 2011 Jun; 30(6):685-90. PubMed ID: 21444211
[TBL] [Abstract][Full Text] [Related]
16. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
[TBL] [Abstract][Full Text] [Related]
17. Design of a robust infrastructure to monitor the safety of the pandemic A(H1N1) 2009 vaccination program in Taiwan.
Huang WT; Chen WW; Yang HW; Chen WC; Chao YN; Huang YW; Chuang JH; Kuo HS
Vaccine; 2010 Oct; 28(44):7161-6. PubMed ID: 20804804
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune disorders after immunisation with Influenza A/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review.
Isai A; Durand J; Le Meur S; Hidalgo-Simon A; Kurz X
Vaccine; 2012 Nov; 30(49):7123-9. PubMed ID: 23022149
[TBL] [Abstract][Full Text] [Related]
19. Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean.
Ropero-Álvarez AM; Whittembury A; Bravo-Alcántara P; Kurtis HJ; Danovaro-Holliday MC; Velandia-González M
Vaccine; 2015 Jan; 33(1):187-92. PubMed ID: 25444798
[TBL] [Abstract][Full Text] [Related]
20. Adverse events associated with pandemic influenza vaccines: comparison of the results of a follow-up study with those coming from spontaneous reporting.
Carvajal A; Ortega PG; Sáinz M; Velasco V; Salado I; Arias LH; Eiros JM; Rubio AP; Castrodeza J
Vaccine; 2011 Jan; 29(3):519-22. PubMed ID: 21112311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
